abstract |
The invention provides compounds of the formula: n n n n n n n n n n wherein B is a nucleobase selected from the groups (a) to (d): n n n n n n n n n n and the other variables are as defined in the claims,n nwhich are of use in the treatment or prophylaxis of hepatitis C virus infection, and related aspects. |